170 related articles for article (PubMed ID: 24590570)
1. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
[TBL] [Abstract][Full Text] [Related]
2. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
[TBL] [Abstract][Full Text] [Related]
3. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
[TBL] [Abstract][Full Text] [Related]
4. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass.
Li CY; Jepsen KJ; Majeska RJ; Zhang J; Ni R; Gelb BD; Schaffler MB
J Bone Miner Res; 2006 Jun; 21(6):865-75. PubMed ID: 16753017
[TBL] [Abstract][Full Text] [Related]
6. Bone density, strength, and formation in adult cathepsin K (-/-) mice.
Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D
Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279
[TBL] [Abstract][Full Text] [Related]
7. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice.
Soung do Y; Gentile MA; Duong LT; Drissi H
Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186
[TBL] [Abstract][Full Text] [Related]
8. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin K Deficiency Suppresses Disuse-Induced Bone Loss.
Moriya S; Izu Y; Arayal S; Kawasaki M; Hata K; Pawaputanon Na Mahasarakhahm C; Izumi Y; Saftig P; Kaneko K; Noda M; Ezura Y
J Cell Physiol; 2016 May; 231(5):1163-70. PubMed ID: 26460818
[TBL] [Abstract][Full Text] [Related]
10. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
11. Acute hematopoietic stress in mice is followed by enhanced osteoclast maturation in the bone marrow microenvironment.
Kuzmac S; Grcevic D; Sucur A; Ivcevic S; Katavic V
Exp Hematol; 2014 Nov; 42(11):966-75. PubMed ID: 25051532
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible.
Zhuo Y; Gauthier JY; Black WC; Percival MD; Duong LT
Bone; 2014 Oct; 67():269-80. PubMed ID: 25038310
[TBL] [Abstract][Full Text] [Related]
14. Investigation of osteoclast cathepsin K activity in osteoclastogenesis and bone loss using a set of chemical reagents.
Janiszewski T; Kołt S; Ciastoń I; Vizovisek M; Poręba M; Turk B; Drąg M; Kozieł J; Kasperkiewicz P
Cell Chem Biol; 2023 Feb; 30(2):159-174.e8. PubMed ID: 36696904
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K Controls Cortical Bone Formation by Degrading Periostin.
Bonnet N; Brun J; Rousseau JC; Duong LT; Ferrari SL
J Bone Miner Res; 2017 Jul; 32(7):1432-1441. PubMed ID: 28322464
[TBL] [Abstract][Full Text] [Related]
16. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice.
Saftig P; Hunziker E; Everts V; Jones S; Boyde A; Wehmeyer O; Suter A; von Figura K
Adv Exp Med Biol; 2000; 477():293-303. PubMed ID: 10849757
[TBL] [Abstract][Full Text] [Related]
17. The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K.
Fuller K; Lindstrom E; Edlund M; Henderson I; Grabowska U; Szewczyk KA; Moss R; Samuelsson B; Chambers TJ
Bone; 2010 May; 46(5):1400-7. PubMed ID: 20097319
[TBL] [Abstract][Full Text] [Related]
18. An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice.
Panwar P; Xue L; Søe K; Srivastava K; Law S; Delaisse JM; Brömme D
J Bone Miner Res; 2017 Dec; 32(12):2415-2430. PubMed ID: 28745432
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function.
Chen W; Zhu G; Jules J; Nguyen D; Li YP
J Bone Miner Res; 2018 Apr; 33(4):691-703. PubMed ID: 29149533
[TBL] [Abstract][Full Text] [Related]
20. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
